Immunovant Inc.

AI Score

XX

Unlock

15.18
-1.91 (-11.18%)
At close: Apr 01, 2025, 3:59 PM
15.01
-1.13%
Pre-market: Apr 02, 2025, 04:13 AM EDT

Immunovant Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -16.83 -9.05 -3.86 -13.1 -10.13 -319.27K -0.73
PEG Ratio -1.69 -0.46 -0.22 0.63 n/a 3.19K n/a
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio 7.07 5.27 1.29 3.60 7.15 5.83K -66.47
P/FCF Ratio -20.34 -10.13 -5.68 -16.85 -12.6 -5 -0.78
P/OCF Ratio -20.38 -10.14 -5.7 -16.89 -12.61 -5.01 -0.78
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.00 0.00 0.01 0.01 0.03 12.22 n/a
Quick Ratio 13.70 9.34 11.52 21.79 7.12 0.85 0.07
Current Ratio 13.70 9.34 11.52 21.79 7.12 0.85 0.07
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -15.9 -238.41 n/a -105.07 n/a n/a
Return on Equity -0.42 -0.58 -0.33 -0.27 -0.71 -0.02 91.36
Return on Assets -0.39 -0.52 -0.3 -0.26 -0.61 n/a -1.21K
Return on Invested Capital -0.46 -0.55 -0.33 -0.27 -0.68 -0.06 91.36
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a